GGrantIndex
Sort

50,496 grants matching lung cancer

Evaluation of genetic, clinical and environmental risk factors to establish effective screening strategies for second primary lung cancer

$648,460
Summer S Han · Stanford University · R37 · FY2023 · CA

IMPACT: INFLUENCING MEDIA & PUBLIC AGENDA ON CANCER & TOBACCO DISPARITIES

$648,321
Kasisomayajula Viswanath · Harvard School Of Public Health · P50 · FY2012 · CA

New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells

$648,309
Traci Leigh Hilton · Ubivac, Llc · R44 · FY2012 · CA

Targeting polo-like kinase 1 (PLK1) for treatment of small cell lung cancer

$648,269
Taofeek K Owonikoko · University Of Maryland Baltimore · R01 · FY2025 · CA

Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer

$648,229
Christian Maximillian Schmidt · Indiana University Indianapolis · U01 · FY2023 · CA

Evaluating Cigarette Relighting Behavior: Prevalence, Correlates, Toxicant Exposure, and Implications for Cessation

$648,215
Michael B. Steinberg · Rutgers Biomedical And Health Sciences · R01 · FY2025 · CA

Next Gen Targeted nanoparticles for Inhibiting Gli2 in Bone Metastatic Tumors

$648,024
Julie A Sterling · Vanderbilt University Medical Center · R01 · FY2025 · CA

UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10

$648,000
Joan H Schiller · Ut Southwestern Medical Center · U10 · FY2014 · CA

Ethnicity and Lung Cancer Survival: A Test of the Hispanic Sociocultural Hypothesis

$647,926
John M Ruiz · University Of Arizona · R01 · FY2025 · CA

Non-rotating nano-optic endoscope for 360 degree in vivo imaging

$647,900
David C Adams · Massachusetts General Hospital · R21 · FY2024 · EB

Revisiting Prior Cancer as an Exclusion Criterion for Cancer Clinical Trials

$647,891
Sandi Leigh Pruitt · Ut Southwestern Medical Center · R01 · FY2022 · CA

A comprehensive canine genetics resource including gene and variation annotation

$647,888
Elinor Karlsson · Broad Institute, Inc. · R24 · FY2016 · OD

Nanoparticle Drug Delivery in Post-Pneumonectomy Compensatory Lung Growth

$647,625
Connie C. W. Hsia · Ut Southwestern Medical Center · U01 · FY2013 · HL

Comparative Effectiveness of Limited Resection vs. Stereotactic Body Radiation Therapy for Early Stage Lung Cancer

$647,610
Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA

Tracking Peripheral T-Cell Repertoire Changes for Preoperative and Early Ovarian Cancer Diagnosis

$647,582
Bo Li · Children'S Hosp Of Philadelphia · R01 · FY2023 · CA

Development of 3D Alveolar Tissue Models, CRISPR-editing and Microbiota-immune Response Assay Platforms for Deciphering Human Lung Immunity

$647,518
Derya Unutmaz · Jackson Laboratory · U19 · FY2020 · AI

A CHEMICAL PROTEOMIC STRATEGY FOR MAPPING CODEPENDENCY PATHWAYS IN KRAS-DRIVEN LUNG CANCER

$647,500
Scripps Research Institute · · FY2020 · Department of the Army

Ethnicity and Lung Cancer Survival: A Test of the Hispanic Sociocultural Hypothesis

$647,425
John M Ruiz · University Of Arizona · R01 · FY2022 · CA

Individual and social contextual factors in relation to DNA methylation, biological aging, and lung cancer risk

$647,413
Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2021 · MD

Disparities in access to and outcomes of cancer surgery for rural Medicare patients

$647,401
Anna N. A. Tosteson · Dartmouth College · R01 · FY2022 · CA

Regulatory T cells in cancer therapy

$647,392
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2025 · CA

Regulatory T cells in cancer therapy

$647,349
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2021 · CA

Individual and social contextual factors in relation to DNA methylation, biological aging, and lung cancer risk

$647,326
Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2023 · MD

Assessing Telephone All Nations Breath of Life for Efficacy

$647,325
Sean Michael Daley · Lehigh University · R01 · FY2023 · DA

Tools for Linking and Mining image and Genomic Data in Non-Small Cell Lung Cancer

$647,271
Sandy A Napel · Stanford University · R01 · FY2011 · CA